Abstract

Assessment of bone graft material efficacy is difficult in humans, since invasive methods like staged CT scans or biopsies are ethically unjustifiable. Therefore, we developed a novel large animal model for the verification of a potential transformation of synthetic bone graft substitutes into vital bone. The model combines multiple imaging methods with corresponding histology in standardized critical sized cancellous bone defect. Cylindrical bone voids (10 ml) were created in the medial femoral condyles of both hind legs (first surgery at right hind leg, second surgery 3 months later at left hind leg) in three merino‐wool sheep and either (i) left empty, filled with (ii) cancellous allograft bone or (iii) a synthetic, gentamicin eluting bone graft substitute. All samples were analysed with radiographs, MRI, μCT, DEXA and histology after sacrifice at 6 months. Unfilled defects only showed ingrowth of fibrous tissue, whereas good integration of the cancellous graft was seen in the allograft group. The bone graft substitute showed centripetal biodegradation and new trabecular bone formation in the periphery of the void as early as 3 months. μCT gave excellent insight into the structural changes within the defects, particularly progressive allograft incorporation and the bone graft substitute biodegradation process. MRI completed the picture by clearly visualizing soft tissue ingrowth into unfilled bone voids and presence of fluid collections. Histology was essential for verification of trabecular bone and osteoid formation. Conventional radiographs and DEXA could not differentiate details of the ongoing transformation process. This model appears well suited for detailed in vivo and ex vivo evaluation of bone graft substitute behaviour within large bone defects.

Highlights

  • Establishment and effects of allograft and synthetic bone graft substitute treatment of a critical size metaphyseal bone defect model in the sheep femur

  • The bone voids were treated with either: (i) no filling, (ii) filling with allograft or (iii) filling with a ceramic, gentamicin eluting bone graft substitutes (BGS) (CERAMENTÒ|G, BONESUPPORT AB, Lund, Sweden). This bio-composite consists of 60% calcium sulphate and 40% hydroxyapatite combined with the antibiotic gentamicin 17.5 mg/1 ml paste, initial porosity 20–40%, initial pore size 1 lm, increasing with calcium sulphate dissolution [9]

  • In order to replicate the clinical scenario of a metaphyseal bone resection, the largest possible standardized bone voids amenable to this bone region were created with a diameter of 25 mm and a depth of 20 mm

Read more

Summary

MATERIALS AND METHODS

Three healthy female merino-wool sheep (age 2.5 years at first surgery) were used for this study and institutional guidelines regarding care of animals were followed.

Study design
RESULTS
DISCUSSION
A T1 cor
Limitations
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call